16
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16363 | NVP-2 | Apoptosis , CDK | |
NVP-2 is an effective and selective ATP-competitive cyclin-dependent kinase 9 (CDK9) probe. NVP-2 induces cell apoptosis. NVP-2 inhibits CDK9/CycT activity (IC50: 0.514 nM). NVP-2 shows inhibitory effcts on CDK1/CycB, CD... | |||
T1918 | NVP-TAE 226 | TAE226 | Apoptosis , FAK , c-Met/HGFR , PYK2 , IGF-1R |
NVP-TAE 226 (TAE226) is an effective FAK inhibitor (IC50: 5.5 nM) and most effective to Pyk2(IC50: 3.5 nM); 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK. | |||
TQ0231 | NVP-CGM097 | CGM097 | Mdm2 , E1/E2/E3 Enzyme |
NVP-CGM097 (CGM097) is an effective and specific MDM2 inhibitor (IC50: 1.7 nM for hMDM2). | |||
T5555 | Siremadlin | NVP-HDM 201 | E1/E2/E3 Enzyme |
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor. | |||
T1502 | Vildagliptin | NVP-LAF 237,LAF237 | Apoptosis , Ferroptosis , Proteasome , DPP-4 |
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolit... | |||
T2235 | Dactolisib | BEZ235,NVP-BEZ235 | ATM/ATR , PI3K , mTOR , Autophagy |
Dactolisib (BEZ235) is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR). | |||
T2251 | NVP-TAE 684 | TAE684 | Apoptosis , ALK |
NVP-TAE 684 (TAE684) is a excellently effective and specific ALK inhibitor(IC50=3 nM). | |||
T33763 | NVP CXCR2 20 | NVP-CXCR2 20,NVP CXCR2-20,NVP CXCR220 | |
NVP CXCR2 20 is an effective selective CXCR2 antagonist (IC50 = 40 nM) with oral bioavailability. | |||
T5049 | NVP-BSK805 | NVP-BSK805 2HCl,BSK 805 | Tyrosine Kinases , JAK |
NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor. | |||
T3463 | NVP-ACC789 | ACC-789,ZK202650 | VEGFR , PDGFR |
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases. | |||
T1975 | Infigratinib | BGJ-398,NVP-BGJ398 | Apoptosis , FGFR |
Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2. | |||
T1933 | NVP 231 | Apoptosis , ERK | |
NVP-231 is a potent, specific and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits ceramide binding to CerK. | |||
T2116 | AEE788 | NVP-AEE 788 | Apoptosis , EGFR , c-Fms , FLT , Bcr-Abl |
AEE788 (NVP-AEE 788) has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors. | |||
T6079 | NVP-ADW742 | ADW742,ADW,GSK 552602A | Apoptosis , IGF-1R |
NVP-ADW742 (ADW) is an IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR; little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit. | |||
T25894 | NVP-AAD777 | AAD-777,NVP-AAD-777,NVP AAD 777 | |
NVP-AAD777 is a specific VEGFR-2 inhibitor. | |||
T74717 | 12-Hydroxynevirapine | ||
12-Hydroxynevirapine (12-hydroxy-NVP; 12-OH-NVP), a significant oxidative metabolite of Nevirapine—an antiviral drug used for HIV-1 infections known for potential idiosyncratic hepatotoxicity and skin rashes—undergoes bi... |